nonalcoholic steatohepatitis
-
Madrigal Pharmaceuticals Plans $500 Million Stock Offering While Awaiting Nod from FDA
Conshohocken-based Madrigal Pharmaceuticals plans to raise $500 million while anticipating FDA approval of a groundbreaking therapy, writes John George for…
-
Stock price surges for small West Conshohcken drug company
Madrigal Pharmaceuticals, West Conshohocken, has experienced a rapid rise in its stock price and market capitalization, which at the start of…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
